Sign in to view content

Impact of COVID-19 and Delay on Macular Edema After Retinal Vein Occlusion (MEfRVO) Comparing Ozurdex vs Anti-VEGF Therapy

John J. Huang, MD

Video
Published 2022

Related

Charlson Comorbidity Index As a Predictive Tool in Patients With Exudative Age-Related Macular Degeneration in Delay of Care
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2024
Modeling the Effect of Longer-Acting Drugs and Reimbursement Changes
Robert A Diamond, BBA
Updates from the Field
2022
Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies
David M. Brown, MD
Updates from the Field
2021

Category: Retinal Vascular Disease

See more